04:13 PM EDT, 08/23/2024 (MT Newswires) -- Peter Salzmann, Director, Chief Executive Officer, on August 21, 2024, sold 15,068 shares in Immunovant ( IMVT ) for $480,052. Following the Form 4 filing with the SEC, Salzmann has control over a total of 1,008,344 shares of the company, with 1,008,344 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1764013/000176401324000156/xslF345X05/wk-form4_1724443632.xml